Verrica Pharmaceuticals Inc
1NE
Company Profile
Business description
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Contact
44 West Gay Street
Suite 400
West ChesterPA19380
USAT: +1 484 453-3300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
71
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,828.70 | 56.70 | 0.65% |
| CAC 40 | 7,726.26 | 63.67 | 0.83% |
| DAX 40 | 23,693.89 | 20.60 | 0.09% |
| Dow JONES (US) | 44,494.94 | 400.17 | 0.91% |
| FTSE 100 | 8,753.11 | 32.22 | -0.37% |
| HKSE | 24,221.41 | 149.13 | 0.62% |
| NASDAQ | 20,202.89 | 166.84 | -0.82% |
| Nikkei 225 | 39,762.48 | 223.85 | -0.56% |
| NZX 50 Index | 12,784.29 | 49.76 | 0.39% |
| S&P 500 | 6,198.01 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,597.70 | 56.60 | 0.66% |
| SSE Composite Index | 3,454.79 | 2.95 | -0.09% |